The data displays the leading analgesic-internal tablet brands in the U.S. in 2017, based on sales. In that year, private labels were the leading U.S. analgesic-internal tablet brands with sales of approx. 1.21 billion USD.
Private label | 1205.8 |
Advil | 484 |
Aleve | 338.9 |
Tylenol | 299.2 |
Bayer | 216 |
Excedrin Migraine | 88.5 |
Advil PM | 87.1 |
Excedrin | 74.3 |
Motrin IB | 70.4 |
BC | 50.5 |